Pharmacokinetic properties of Gammagard Liquid 10% (KIOVIG) administered intravenously and subcutaneously to patients with primary immunodeficiency diseases (PID)

被引：0

作者：

Schiff, R., I ^{[1
]}

Leibl, H. ^{[1
]}

Engl, W. ^{[1
]}

机构：

[1] Baxter Healthcare Corp, Westlake Village, CA USA

来源：

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2008年 / 154卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：132 / 132

页数：1

共 50 条

[1] IGIV-10% Infused Intravenously And Subcutaneously To Subjects With Primary Immunodeficiency Diseases - Comparison Of Pharmacokinetic Properties
Leibl, H.
Engl, W.
Melamed, I.
Stein, M.
Wasserman, R. L.
Berger, M.
Schiff, R. I.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S11 - S11
[2] Efficacy, Safety, and Pharmacokinetics of a 10% Liquid Immune Globulin Preparation (GAMMAGARD LIQUID, 10%) Administered Subcutaneously in Subjects with Primary Immunodeficiency Disease
Richard L. Wasserman
Isaac Melamed
Lisa Kobrynski
Steven D. Strausbaugh
Mark R. Stein
Marlies Sharkhawy
Werner Engl
Heinz Leibl
Luba Sobolevsky
David Gelmont
Richard I. Schiff
William J. Grossman
Journal of Clinical Immunology, 2011, 31 : 323 - 331
[3] Efficacy, Safety, and Pharmacokinetics of a 10% Liquid Immune Globulin Preparation (GAMMAGARD LIQUID, 10%) Administered Subcutaneously in Subjects with Primary Immunodeficiency Disease
Wasserman, Richard L.
Melamed, Isaac
Kobrynski, Lisa
Strausbaugh, Steven D.
Stein, Mark R.
Sharkhawy, Marlies
Engl, Werner
Leibl, Heinz
Sobolevsky, Luba
Gelmont, David
Schiff, Richard I.
Grossman, William J.
JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (03) : 323 - 331
[4] Pharmacokinetic Analysis (PK) of Immune Globulin Subcutaneous (Human), 10% (IGSC) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases (PIDD)
Leibl, H.
Wasserman, R. L.
Melamed, I.
Stein, M.
Engl, W.
Schiff, R. I.
Gelmont, D.
Grossman, W. J.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB17 - AB17
[5] Efficacy Analysis of Subcutaneous Immune Globulin (HUMAN), 10 % (SCIG 10 %) Administered Intravenously or Subcutaneously in Patients with Primary Immunodeficiency Diseases (PIDD)
Wasserman, Richard L.
Kobrynski, Lisa
Stein, Mark
Engl, Werner
Berner, Todd
Leibl, Heinz
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S55 - S55
[6] Human immunoglobulin (KIOVIG®/GAMMAGARD LIQUID®) for immunodeficiency and autoimmune diseases: an observational cohort study
Blazek, Bohumir
Misbah, Siraj A.
Soler-Palacin, Pere
McCoy, Barbara
Leibl, Heinz
Engl, Werner
Empson, Victoria
Gelmont, David
Nikolov, Nikolai
IMMUNOTHERAPY, 2015, 7 (07) : 753 - 763
[7] IGIV 10%, Infused Intravenously, and Subcutaneously to Subjects With Primary Immunodeficiency Diseases-Efficacy, Tolerability, and Pharmacokinetic Comparison
Schiff, R. I.
Leibl, H.
Wasserman, R. L.
Stein, M.
Melamed, I.
CLINICAL IMMUNOLOGY, 2010, 135 (02) : 323 - 323
[8] Efficacy Analysis of Immune Globulin Subcutaneous (Human), 10% (IGSC) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases (PIDD)
Schiff, R. I.
Wasserman, R. L.
Melamed, I.
Stein, M.
Engl, W.
Leibl, H.
Gelmont, D.
Grossman, W. J.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB15 - AB15
[9] Recombinant human hyaluronidase facilitates dispersion of subcutaneously administered Gammagard liquid and enables administration of a full monthly bose in a single site to patients with immunodeficiency diseases
Melanned, I. R.
Stein, M. R.
Wasserman, R. L.
Leibl, H.
Engl, W.
Yocum, R. C.
Schiff, R. I.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S83 - S83
[10] PHARMACOKINETICS OF HUMAN IMMUNOGLOBULIN G, 10%, ADMINISTERED INTRAVENOUSLY (IGIV), SUBCUTANEOUSLY (IGSC) OR FACILITATED SUBCUTANEOUSLY WITH RECOMBINANT HUMAN HYALURONIDASE (IGHY): SUBSET OF PATIENTS WITH PRIMARY IMMUNODEFICIENCY
Stein, M.
Wasserman, R. L.
Melamed, I.
Puck, J.
Gupta, S.
Engl, W.
Leibl, H.
Gelmont, D.
Schiff, R. I.
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 156 - 157

← 1 2 3 4 5 →